PacBio joins iHope initiative as first long-read genomic sequencing partner
Integration of HiFi long-read whole-genome sequencing expands the collective capabilities of iHope’s global rare disease network
Integration of HiFi long-read whole-genome sequencing expands the collective capabilities of iHope’s global rare disease network
Roadmap advances provide flexibility across targeted and whole genome applications
Experts explore the technologies and innovations transforming organoids into scalable platforms for drug discovery
The study shows that some of the genetic changes in cat tumors closely resemble those found in human cancers, opening up new perspectives for developing targeted cancer therapies, particularly for breast cancer
Streamlining complex molecular and clinical workflows with the Lynx® platform and collaborative solutions
Advancing global operations and realigning domestic sites to strengthen the organization
The collaboration shortens timelines and helps customers move from lab concept to compliant, high-volume production for healthcare and industrial applications
Breakthrough technology delivers 100–400 nt RNA with exceptional purity, enabling faster design cycles and improved editing precision
EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights
In our SelectScience NGS Forum, genomics leaders discussed the challenges and opportunities driving the next chapter of next-generation sequencing
New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery
As an ambassador for the Women in STEM Network, Dr. Vasiliki E. Kalodimou is mentoring future scientists and redefining what is possible for women
B&R will highlight how these technologies support high throughput, flexibility, and consistent laboratory performance at scale
Troubleshoot automation workflows using plain English instead of code with the Green Button Go
In this guest editorial, Dr. Megan O’Shaughnessy of ICON plc shares how non-invasive testing has the potential to transform the management of metabolic liver disease
QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight
New workflow, validated on the Dynamic Devices Lynx delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes without compromising yield or quality
Expansion accelerates the development of its non-invasive cancer diagnostic solutions
From sample limitations to isomeric separations, see how the right column choice transformed a challenging lipidomics project
See how Nautilus Biotechnology’s Iterative Mapping platform combines ultra-sensitive protein analysis and AI-driven insights for deeper biological understanding